kotak-logo
Jenburkt Pharmaceuticals Share Price

Jenburkt Pharmaceuticals Share Price

1000
-0.30 (-0.03%)
JENBURPH • 09 Mar, 2026 | 03:20 PM

1Y Annualised Return

0.31%

3Y Annualised Return

15.51%

5Y Annualised Return

20.37%

10Y Annualised Return

9.47%

Jenburkt Pharmaceuticals Stock Performance

1W Return0.20
1Y Return1.95
Today's Low970
Prev. Close1,000.30
Mkt Cap (Cr.)441.46
1M Return-6.35
3Y Return51.99
52-Week High1410
Open980.00
PE Ratio13.62
6M Return-10.48
Today's High1000
52-Week Low944
Face Value10

Jenburkt Pharmaceuticals Company background

Founded in: 1985
Managing director: Ashish U Bhuta
Jenburkt Pharmaceuticals Limited, incorporated in 1985, was formed a joint venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe. The organisation caters to government, semigovernment institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at SihorGujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements. In addition, it has a Research Development unit duly approved by the Ministry of Science Technology, Government of India. Hence, the Company has strong manufacturing facilities to cater to domestic and international market.The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, lifechanging therapeutic solutions that are accessible to all. Way back in the 20th century, a visionary in the field of healthcare and philanthropic work Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies. Continuing the legacy of Shri Nandlal Mulji Bhuta, his sons Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta founded the Company.In 202122, the Company launched a new OTC division Jenburkt Wellness towards better physical and mental health. The first brand launched was Zixa Strong, natural, pain relief product. Further, it launched Nervijen D3 tablets in 202223.Nervijen D3 tablets became the first brand in 2025 to reach a revenue target exceeding during the year.

Jenburkt Pharmaceuticals Share Price Today


As of 9 Mar 2026, Jenburkt Pharmaceuticals share price is ₹1000. The stock opened at ₹980 and had closed at ₹1000.3 the previous day. During today’s trading session, Jenburkt Pharmaceuticals share price moved between ₹970.00 and ₹1,000.00, with an average price for the day of ₹985.00. Over the last 52 weeks, the stock has recorded a low of ₹944.00 and a high of ₹1,410.00. In terms of performance, Jenburkt Pharmaceuticals share price has declined by 12.4% over the past six months and has increased by 0.31% over the last year.
Read More
Jenburkt Pharmaceuticals SIP Return Calculator
5,000
Over the past
Total Investment of ₹3,00,000
Monthly SIP of 5,000 would have become 5,22,856 in 5 years with a gain of 2,22,856 (+74.29%)
View details of Market Depth

Jenburkt Pharmaceuticals Fundamental

Market Cap (in crs)

441.46

Face Value

10

Turnover (in lacs)

10.79

Key Metrics

Qtr Change %
New 52W Low in past week
-7
Dividend yield 1yr %
High in industry
1.8

Jenburkt Pharmaceuticals Technical Analysis

Moving Averages Analysis
1000
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
Day EMA5
1,001.10
Day EMA10
1,008.20
Day EMA12
1,011.50
Day EMA20
1,023.80
Day EMA26
1,031.60
Day EMA50
1,056.00
Day EMA100
1,087.00
Day EMA200
1,106.80
Delivery & Volume
Loading chart...

Day

91.40%

Week

81.30%

Month

79.80%

Delivery & Volume

1,002.77
Pivot
Resistance
First Resistance
1,010.53
Second Resistance
1,020.77
Third Resistance
1,028.53
Support
First Support
992.53
Second support
984.77
Third Support
974.53
Relative Strength Index
38.31
Money Flow Index
39.49
MACD
-20.12
MACD Signal
-18.66
Average True Range
35.06
Average Directional Index
33.68
Rate of Change (21)
-5.36
Rate of Change (125)
-13.99
Compare

Jenburkt Pharmaceuticals Shareholding Pattern

Promoter
46.6%
Domestic Institutions
0.1%
Public
53.2%

Jenburkt Pharmaceuticals Latest News

04 FEB 2026 | Wednesday
03 FEB 2026 | Tuesday
03 FEB 2026 | Tuesday

Please be aware that Jenburkt Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.